ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 134 filers reported holding ZAI LAB LTD in Q2 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,399 | +14.8% | 181 | +31.2% | 0.00% | – |
| Q2 2023 | $3,831 | -16.5% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $4,588 | -23.5% | 138 | -29.9% | 0.00% | – |
| Q4 2022 | $6,000 | +20.0% | 197 | +39.7% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 141 | -41.5% | 0.00% | – |
| Q2 2022 | $8,000 | -11.1% | 241 | +0.8% | 0.00% | – |
| Q1 2022 | $9,000 | 0.0% | 239 | +62.6% | 0.00% | – |
| Q4 2021 | $9,000 | -77.5% | 147 | -61.3% | 0.00% | – |
| Q3 2021 | $40,000 | -36.5% | 380 | +6.4% | 0.00% | – |
| Q2 2021 | $63,000 | +53.7% | 357 | +16.3% | 0.00% | – |
| Q1 2021 | $41,000 | +78.3% | 307 | +74.4% | 0.00% | – |
| Q4 2020 | $23,000 | +91.7% | 176 | +8.6% | 0.00% | – |
| Q3 2020 | $12,000 | +71.4% | 162 | +88.4% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 86 | -31.2% | 0.00% | – |
| Q1 2020 | $7,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |